Do You Lose More Weight with Ozempic or Mounjaro?

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and tirzepatide are the two most prescribed GLP-1 medications for weight loss, yet they work through different biological pathways and produce measurably different results. Clinical trials show tirzepatide produces greater average weight loss than semaglutide, but individual response varies widely based on genetics, lifestyle, and metabolic factors. PlexusDx helps you access both options and identify which may work best for your body.

Semaglutide vs Tirzepatide: How They Differ at the Cellular Level

Semaglutide works by activating GLP-1 receptors, a single hormone pathway that signals fullness and reduces appetite. Tirzepatide activates both GLP-1 and GIP receptors, creating a dual-hormone signal that suppresses appetite while also improving how your body metabolizes glucose and fat. This dual-receptor activation is why tirzepatide is sometimes called a GIP/GLP-1 receptor agonist, and it fundamentally changes how your metabolism responds to food and energy.

The GIP pathway (glucose-dependent insulinotropic peptide) appears especially important for reducing hunger and boosting metabolic rate in people who carry certain genetic variants. Semaglutide's single-pathway approach remains highly effective for many patients, but it leaves the GIP system unstimulated. Understanding which pathway your body responds to most strongly is where personalized testing becomes valuable.

Clinical Trial Data: Weight Loss Outcomes You Should Know

The STEP trials (semaglutide) showed average weight loss of 15-18% of body weight over 68 weeks at the highest doses tested. The SURMOUNT trials (tirzepatide) demonstrated average weight loss of 21-23% of body weight over similar timeframes, representing roughly 3-5 percentage points more loss than semaglutide. Both are substantially more effective than older weight loss medications, but the tirzepatide advantage appears consistent across multiple trial populations.

Response variability within each medication group is also important to understand: some patients lose 30%+ of body weight on either medication, while others may see more modest results. Sex, baseline metabolic rate, genetic ancestry, and GLP-1 receptor sensitivity all influence individual outcomes. Trial data represents averages, not guarantees, which is why starting with the right medication for your specific biology matters.

Why Individual Genetics Matter More Than Average Trial Results

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Mounjaro or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Cost, Access, and How PlexusDx Fits Into Your Decision

PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan and compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan—both flat pricing regardless of dose level. Your dose may need to go up. Your price won't. All medications come from licensed 503A compounding pharmacies, require no insurance or membership fee, and are HSA/FSA eligible. This pricing structure removes the financial pressure to choose based on cost alone; instead, you can focus on which medication aligns with your metabolism.

PlexusDx also offers GLP-Squared Injection, a dual-compound option combining semaglutide and tirzepatide in one formulation, at $289/mo month-to-month, or from $249/mo on the 6-month plan for patients who want to activate both pathways simultaneously. After your first month of treatment, the Precision Peptide Genetic Test ($298) can reveal your genetic response profile, helping you and your provider refine your medication strategy if needed. All treatments are available in all 50 states with no waiting lists or insurance approval delays.

Side Effects and Tolerability: What Differs Between the Two

Both semaglutide and tirzepatide cause nausea, vomiting, and gastrointestinal changes in a significant portion of users, especially during the first 2-4 weeks and when doses increase. Tirzepatide carries a slightly higher rate of gastrointestinal side effects in clinical trials, likely due to its dual-pathway activation. Most side effects diminish over time as the body adjusts, but some patients cannot tolerate GLP-1 medications at all regardless of which one they try.

If side effects prevent you from tolerating injections, PlexusDx offers oral semaglutide (is $289/mo month-to-month (or $249/mo on the 6-month plan)) and oral tirzepatide (is $349/mo month-to-month (or $279/mo on the 6-month plan)), though oral formulations require specific timing and may not absorb as efficiently as injections. Your healthcare provider can help monitor tolerability and switch medications if needed without incurring additional membership or setup fees.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Does tirzepatide always produce more weight loss than semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What does the GIP receptor actually do in weight loss?

The GIP receptor helps regulate appetite suppression, glucose metabolism, and energy expenditure independently from the GLP-1 pathway. By activating both GLP-1 and GIP receptors, tirzepatide creates a more comprehensive metabolic signal than semaglutide alone. People with genetic variants that enhance GIP responsiveness often see more dramatic weight loss on tirzepatide.

How much does PlexusDx charge, and can I switch medications without extra fees?

PlexusDx charges a flat monthly fee: semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan), with no flat per-compound pricing increases. You can switch between medications anytime without membership fees, setup charges, or insurance requirements. All medications are HSA/FSA eligible and available in all 50 states.

Are compounded semaglutide and tirzepatide as safe as FDA-approved versions?

PlexusDx sources all medications from licensed 503A compounding pharmacies that follow strict quality standards. Compounded medications are not FDA-approved but are prepared under federal oversight and pharmacist supervision. Discuss compounded medication options with your healthcare provider to determine if they're right for you.

How can the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?

No — the Precision Peptide Genetic Test does not predict your response to GLP-Squared or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.